Risk factors of death in patients with COPD
N. Karoli, A. Rebrov (Saratov, Russian Federation)
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Session: Prognosis and comorbidities in COPD
Session type: E-Communication Session
Number: 518
Disease area: Airway diseases
Abstract The risk of death in patients with COPD is often graded with the use of a single physiological parameter, the FEV1. However, other risk factors can also associate with an increased risk of death. We prospective study a cohort of 90 patients with COPD (age 54,99±0,87 yrs, 100% male), with we observed in period of 3-5 years. 78.9% of them was with severe COPD. There were 25 (27.8%) deaths over a mean follow-up period 42 months (range, 0.5 to 60). The majority of patients (88%) died of respiratory insufficiency and/or heart failure, 2 patients died of myocardial infarction, 1 patient of cancer. The died patients were higher (p<0,05), had the large duration of dyspnoe (p<0.05), intensity and duration of smoking (p<0.01 and p<0.01). Also died patients had lower FEV1 (p<0.05), SaO2 (p<0.01) and more bad result of the 6-min walking test (p<0.001) then survival pts. The died patients had more expressed pulmonary hypertension (p<0.001), right ventricular (RV) hypertrophy (p<0.001) and dilatation (p < 0.001), right trial dilatation (p<0.05). At this category of the patients is more expressed RV diastolic dysfunction. Thus, our data suggests that the risk factors of death of the patients with COPD are FEV1<40%, SaO2<90%, 6-minute walking test result< 300 M, pulmonary artery systolic pressure ≥40 mm Hg, RV wall ≥0,7 cm, RV diameter ≥ 3,0 cm, RV diastolic dysfunction, development of clinical symptoms of heart failure. The risk of death is higher at the elderly patients (>60 yrs) with dyspnoe duration > 10 yrs, duration of smoking >40 yrs, intensity of smoking ≥50 packs/years.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Karoli, A. Rebrov (Saratov, Russian Federation). Risk factors of death in patients with COPD. Eur Respir J 2009; 34: Suppl. 53, 518
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009
Risk factors for COPD Source: Eur Respir J 2006; 28: Suppl. 50, 448s Year: 2006
Risk factors of reintubation among patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 313s Year: 2007
Risk factors associated with hospitalized asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 51s Year: 2001
Risk factors of mortality in COPD patients with ventilator associated pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 50s Year: 2007
Risk factor biomarker differences in rehospitalization for patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 838s Year: 2006
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
Predictor factors of mortality in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 808s Year: 2006
Risk factors for hospitalization of an acute exacerbation of COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 177s Year: 2006
Risk factors for COPD mortality in women in the UK Source: Eur Respir J 2006; 28: Suppl. 50, 463s Year: 2006
Risk factors of near fatal asthma in elderly patients Source: Eur Respir J 2001; 18: Suppl. 33, 52s Year: 2001
Predictive factors of mortality in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 76s Year: 2007
Modifiable risk factors for all-cause hospitalization in obstructive lung disease Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015
Risk factors for long-term hospitalization in patients with COVID 19 Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005
Prevalence and risk factors of depression in patients with COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Analysis of causes of death and mortality risk factors in elderly patients hospitalized due to pneumonia Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Risk factors for lung cancer in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017